어플

Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Business / Kim Jisun / 08/14/2024 03:32 AM

Seo Jung-jin, honorary chairman of Celltrion (photo= Celltrion)

 

[Alpha Biz= Reporter Kim Jisun] Celltrion's Yuflyma to Accelerate Prescription Growth with Costco Sale

Celltrion announced on August 13 that its self-immune disorder treatment, Yuflyma (ingredient: adalimumab), is now available for purchase at Costco, a major U.S. retailer. The drug was registered with the Costco Member Prescription Program (CMPP) as of August 1 (local time).

The CMPP allows Costco members to buy medications at discounted prices from in-store or affiliated pharmacies. Starting this month, uninsured Costco members and their dependents can purchase Low WAC Yuflyma at a reduced price from Costco stores and partner pharmacies across the U.S.

 

 

 

AlphaBIZ Kim Jisun(stockmk2020@alphabiz.co.kr)

Related articles

Netmarble Scraps Netmarble Neo IPO, Moves to Make Unit Wholly Owned Subsidiary
KFTC Launches Probe into Alleged Technology Misappropriation by NextTrade
KFTC Orders Dunamu to Correct Misleading Fee Discount Advertising on Upbit
HD Hyundai Files Injunction Against DAPA Over KDDX Design Disclosure Dispute
Airlines Cut Flights as Jet Fuel Prices Surge Amid Middle East Conflict
comments >

SNS